75069-59-9 Usage
Uses
Used in Pharmaceutical Industry:
20,24-Dihydroxydammar-25-en-3-one is used as a pharmaceutical compound for its anti-inflammatory and antioxidant properties, which may contribute to the treatment of various diseases and conditions.
Used in Cancer Treatment:
In the field of oncology, 20,24-Dihydroxydammar-25-en-3-one is used as a potential therapeutic agent for cancer treatment, given its anti-inflammatory and antioxidant effects that may help in managing the disease.
Used in Diabetes Management:
20,24-Dihydroxydammar-25-en-3-one is used as a potential agent in diabetes management, where its properties may aid in addressing the complications associated with the condition.
Used in Neurodegenerative Disorders:
For neurodegenerative disorders, 20,24-Dihydroxydammar-25-en-3-one is used as a potential therapeutic agent, leveraging its anti-inflammatory and antioxidant properties to mitigate the effects of these conditions.
Used in Wound Healing:
20,24-Dihydroxydammar-25-en-3-one is used as a component in wound healing applications, promoting the healing process due to its beneficial properties.
Used in Immune System Enhancement:
In the context of immune system function, 20,24-Dihydroxydammar-25-en-3-one is used to potentially improve overall immune response and health.
Used as a Precursor in Chemical Synthesis:
20,24-Dihydroxydammar-25-en-3-one is used as a precursor in the synthesis of various pharmaceutical drugs and chemical compounds, highlighting its utility in the development of new treatments and products.
Check Digit Verification of cas no
The CAS Registry Mumber 75069-59-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,0,6 and 9 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 75069-59:
(7*7)+(6*5)+(5*0)+(4*6)+(3*9)+(2*5)+(1*9)=149
149 % 10 = 9
So 75069-59-9 is a valid CAS Registry Number.
75069-59-9Relevant academic research and scientific papers
Pokhilo, N. D.,Malinovskaya, G. V.,Makhan'kov, V. V.,Denisenko, V. A.,Uvarova, N. I.
, (1985)
The compositions of the triterpene fractions of the unsaponifiable part of the ethereal extracts of the leaves of B. nana and B. exilis have been studied.The leaves of B. exilis have yielded a new triterpene for which the structure of 3α,20(S),25-trihypro
